These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27153448)

  • 1. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
    D'souza B; Nayak R; Kotrashetti VS
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
    Zhang G; Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin expression in oral leukoplakia: tumorigenic role.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin expression in oral leukoplakia─a prospective study.
    Grochau KJ; Safi AF; Drebber U; Grandoch A; Zöller JE; Kreppel M
    J Craniomaxillofac Surg; 2019 Mar; 47(3):505-509. PubMed ID: 30638740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin expression as a predictive marker of dysplasia in oral leukoplakia.
    Gissi DB; Gabusi A; Tarsitano A; Luccarini L; Morandi L; Montebugnoli L
    J Craniomaxillofac Surg; 2018 May; 46(5):759-764. PubMed ID: 29588189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
    Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
    Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of podoplanin in oral premalignant and malignant lesions and its potential as a biomarker.
    Logeswari J; Malathi N; Thamizhchelvan H; Sangeetha N; Nirmala SV
    Indian J Dent Res; 2014; 25(3):305-10. PubMed ID: 25098985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
    Parhar S; Kaur H; Vashist A; Verma S
    Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
    Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of CA-IX as a diagnostic method for oral leukoplakia.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Torres-López M; Supuran CT; Gándara-Vila P; Gayoso-Diz P; Barros-Angueira F; Gallas-Torreira M; García-García A
    Biotech Histochem; 2015 Feb; 90(2):124-31. PubMed ID: 25297562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of podoplanin expression to histopathological grades of oral epithelial dysplasia and oral squamous cell carcinoma.
    Shabir H; Durrani SH; Tariq SF; Khatak SS; Khan AS; Arbab KN
    J Pak Med Assoc; 2024 May; 74(5):852-856. PubMed ID: 38783429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications.
    Kreppel M; Kreppel B; Drebber U; Wedemayer I; Rothamel D; Zöller JE; Scheer M
    Oral Dis; 2012 Oct; 18(7):692-9. PubMed ID: 22471854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
    Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
    J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.
    Matta A; Tripathi SC; DeSouza LV; Grigull J; Kaur J; Chauhan SS; Srivastava A; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Michael Siu KW
    Int J Cancer; 2009 Sep; 125(6):1398-406. PubMed ID: 19548310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.
    Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T
    Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.